Cargando…
Phenotypic and genotypic detection of extended spectrum β-lactamases among Escherichia coli and Klebsiella pneumoniae isolates from type 2 diabetic patients with urinary tract infections
BACKGROUND: T2DM patients are more likely to have UTIs caused by resistant organisms such as ESBLs producing bacteria. Challenging reliable identification and prompt characterization of in-vitro susceptibilities of these bacteria are the first steps of deciding the appropriate antimicrobial therapy...
Autores principales: | Elmi, Souad Youssouf Kani, Ashour, Medhat Saber, Alsewy, Fathy Zakaria, Abd El Moez Azzam, Nashwa Fawzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Makerere Medical School
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568203/ https://www.ncbi.nlm.nih.gov/pubmed/34795701 http://dx.doi.org/10.4314/ahs.v21i2.3 |
Ejemplares similares
-
Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020) -
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015) -
Analysis of drug resistance of extended-spectrum beta-lactamases-producing Escherichia coli and Klebsiella pneumoniae in children with urinary tract infection
por: Keshi, Lu, et al.
Publicado: (2019) -
Extended-Spectrum β-Lactamases in Escherichia coli and Klebsiella
pneumoniae in Gulls, Alaska, USA
por: Bonnedahl, Jonas, et al.
Publicado: (2014) -
Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)